Nanogen Co.,Ltd. – FDA Inspection, Feb 21, 2025

Record Details

This FDA Inspection record concerns Nanogen Co.,Ltd., with an inspection on February 21, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Nanogen Co.,Ltd.
Inspection Date: February 21, 2025
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Dennis Cantellops Paite (Issuing Officer)

View Company Profile

ID · e813d81f-d857-4cac-afb6-037626f5f7cc

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1269574
FDA center: Human Drugs
Project area: Drug Quality Assurance

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nanogen Co.,Ltd.

FDA Inspection

Nanogen Co.,Ltd.February 21, 2025